Scout Investments, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Scout Investments, Inc.

$3.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$15.21 - $22.88 $58,026 - $87,287	-3,815 Reduced 2.83%	131,192 $2.07 Million
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $71,864 - $129,105	-4,051 Reduced 2.91%	135,007 $2.62 Million
Q1 2023 May 11, 2023	SELL	$25.06 - $34.09 $39,695 - $53,998	-1,584 Reduced 1.13%	139,058 $3.95 Million
Q4 2022 Jan 23, 2023	SELL	$24.98 - $39.77 $58,503 - $93,141	-2,342 Reduced 1.64%	140,642 $0
Q3 2022 Oct 18, 2022	SELL	$26.42 - $47.12 $107,001 - $190,836	-4,050 Reduced 2.75%	142,984 $3.78 Million
Q2 2022 Jul 15, 2022	SELL	$41.26 - $51.35 $916,137 - $1.14 Million	-22,204 Reduced 13.12%	147,034 $6.53 Million
Q1 2022 Apr 14, 2022	SELL	$44.58 - $52.6 $10,164 - $11,992	-228 Reduced 0.13%	169,238 $8.38 Million
Q4 2021 Jan 14, 2022	SELL	$45.82 - $56.9 $175,032 - $217,358	-3,820 Reduced 2.2%	169,466 $8.63 Million
Q3 2021 Oct 13, 2021	SELL	$43.79 - $55.78 $158,826 - $202,314	-3,627 Reduced 2.05%	173,286 $9.67 Million
Q2 2021 Jul 23, 2021	BUY	$36.86 - $44.5 $1.13 Million - $1.36 Million	30,664 Added 20.97%	176,913 $7.57 Million
Q1 2021 Apr 09, 2021	BUY	$40.32 - $50.97 $575,769 - $727,851	14,280 Added 10.82%	146,249 $6.1 Million
Q4 2020 Jan 12, 2021	BUY	$41.72 - $51.34 $146,020 - $179,690	3,500 Added 2.72%	131,969 $6.15 Million
Q3 2020 Oct 13, 2020	BUY	$37.02 - $51.28 $1.63 Million - $2.26 Million	44,114 Added 52.3%	128,469 $5.46 Million
Q2 2020 Jul 14, 2020	SELL	$43.24 - $55.02 $16,690 - $21,237	-386 Reduced 0.46%	84,355 $4.05 Million
Q1 2020 Apr 16, 2020	SELL	$34.37 - $60.07 $175,596 - $306,897	-5,109 Reduced 5.69%	84,741 $3.9 Million
Q4 2019 Jan 08, 2020	SELL	$54.32 - $64.31 $81,480 - $96,465	-1,500 Reduced 1.64%	89,850 $5.4 Million
Q3 2019 Oct 08, 2019	SELL	$53.25 - $59.98 $397,245 - $447,450	-7,460 Reduced 7.55%	91,350 $5.17 Million
Q2 2019 Jul 10, 2019	BUY	$46.61 - $58.45 $2.04 Million - $2.56 Million	43,815 Added 79.67%	98,810 $5.5 Million
Q1 2019 Apr 12, 2019	SELL	$38.66 - $51.82 $50,876 - $68,195	-1,316 Reduced 2.34%	54,995 $2.78 Million
Q4 2018 Jan 11, 2019	BUY	$36.72 - $67.73 $414,532 - $764,603	11,289 Added 25.07%	56,311 $2.27 Million
Q3 2018 Oct 15, 2018	BUY	$66.65 - $83.86 $3 Million - $3.78 Million	45,022 New	45,022 $3.12 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.

Account